Luxfer Holdings PLC
Luxfer Holdings PLC (LXFR) Financial Performance & Income Statement Overview
Analyze Luxfer Holdings PLC (LXFR) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Luxfer Holdings PLC (LXFR) Income Statement & Financial Overview
Explore comprehensive income reports for Luxfer Holdings PLC LXFR, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $97.00M | $103.40M | $99.40M | $99.70M |
| Cost of Revenue | $75.60M | $80.50M | $77.00M | $77.70M |
| Gross Profit | $21.40M | $22.90M | $22.40M | $22.00M |
| Gross Profit Ratio | $0.22 | $0.22 | $0.23 | $0.22 |
| R&D Expenses | $1.10M | $1.10M | $1.00M | $1.10M |
| SG&A Expenses | $12.60M | $13.20M | $11.40M | $11.90M |
| Operating Expenses | $13.80M | $18.90M | $12.40M | $13.00M |
| Total Costs & Expenses | $89.30M | $99.40M | $89.40M | $90.70M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $1.10M | $1.40M | $1.30M |
| Depreciation & Amortization | $3.10M | $5.90M | $2.60M | $2.50M |
| EBITDA | $11.30M | $10.70M | $20.30M | $16.80M |
| EBITDA Ratio | $0.12 | $0.10 | $0.20 | $0.17 |
| Operating Income | $7.60M | $4.00M | $17.40M | $9.00M |
| Operating Income Ratio | $0.08 | $0.04 | $0.18 | $0.09 |
| Other Income/Expenses (Net) | -$200000.00 | -$300000.00 | -$1.10M | -$1.10M |
| Income Before Tax | $7.40M | $3.70M | $16.30M | $2.70M |
| Income Before Tax Ratio | $0.08 | $0.04 | $0.16 | $0.03 |
| Income Tax Expense | $1.90M | $400000.00 | $3.70M | $3.10M |
| Net Income | $5.50M | $3.50M | $12.70M | -$500000.00 |
| Net Income Ratio | $0.06 | $0.03 | $0.13 | -$0.005 |
| EPS | $0.21 | $0.13 | $0.47 | -$0.02 |
| Diluted EPS | $0.20 | $0.13 | $0.47 | -$0.02 |
| Weighted Avg Shares Outstanding | $26.73M | $26.81M | $26.81M | $26.83M |
| Weighted Avg Shares Outstanding (Diluted) | $27.13M | $26.93M | $26.93M | $26.83M |
Over the past four quarters, Luxfer Holdings PLC demonstrated steady revenue growth, increasing from $99.70M in Q2 2024 to $97.00M in Q1 2025. Operating income reached $7.60M in Q1 2025, maintaining a consistent 8% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $11.30M, reflecting operational efficiency. Net income rose to $5.50M, with EPS at $0.21. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan